Mineralys Therapeutics (NASDAQ:MLYS) Insider David Malcom Rodman Sells 2,171 Shares of Stock
MarketBeat
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 2,171 shares of Mineralys Therapeutics stock in a transaction on Thursday, July 9th. The stock was sold at an average price of $30.30, for a total transaction of $65,781.30. Following the sale, the insider owned 57,733 shares in the company, valued at $1,749,309.90. This represents a 3.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ:MLYS